Announcements Trials
Browse Landscape

Phase

Phase 2 7Phase EARLY_PHASE1 2Phase 3 2Phase 2/3 2Phase NA 1Phase 4 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 1

Conditions

Neoplasms 1Depressive Disorder, Major 1Breast Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 59Cyclophosphamide 44pembrolizumab 34Radiotherapy 30fludarabine 27Nivolumab 26Biopsy 26Metformin 22Fluorodeoxyglucose F18 22Specimen Handling 20Bevacizumab 20Temozolomide 17Radiosurgery 17Cisplatin 16Carboplatin 14Fluorouracil 13Dexamethasone 13Paclitaxel 12Gemcitabine 12Etoposide 12gallium 68 PSMA-11 11durvalumab 11X-Rays 11Surgical Procedures, Operative 11Radiation 11Positron Emission Tomography Computed Tomography 11Letrozole 11Irinotecan 11Ipilimumab 11Surveys and Questionnaires 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × OTHER × Mirtazapine × Clear all
NCT06499090 2026-01-22

Mirtazapine for Acute and Chronic Post Mastectomy Pain

Assiut University

Phase EARLY_PHASE1 Completed
62 enrolled
Breast

Breast Neoplasms

NCT01725048 2017-03-13

NRR

UNC Lineberger Comprehensive Cancer Center

Phase EARLY_PHASE1 Completed
21 enrolled

Depressive Disorder, Major, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡